Whereas the menace from the COVID-19 virus is fading in 2023, one other pathogen is taking its place — microbes proof against most if not all antibiotics and antifungals.
Within the first three months of 2023, public well being officers have reported 4 new well being advisory alerts from micro organism and fungi — dubbed “superbugs” due to their resistance to medicine. They embrace Neisseria gonorrhea (causes the sexually transmitted illness gonorrhea), Candida auris (a fungus that may trigger bloodstream infections), Shigella (causes extreme diarrhea) and Pseudomonas aeruginosa (causes pneumonia and eye infections).
The superbug menace has been bubbling for decades as pharmaceutical corporations have failed to develop new drugs to fight microbes that naturally acquire resistance over time. The hazard, particularly amongst those that are immunocompromised, has grown even graver because the pandemic seemingly accelerated the event of recent resistant pathogens, in part due to overprescribing of antibiotics and elevated use of ventilators and catheters in hospitalized sufferers with COVID-19.
The speedy ascent of resistant bugs like C. auris is “unsettling,” Harry Skinner, CEO of AMR Motion Fund, wrote in STAT, particularly as a result of “the U.S. — and the world has frequently did not take motion towards this menace.”
Valerie Gigante, Ph.D., workforce lead of the World Well being Group’s antimicrobial resistance division added: “Time is working out for us to carry new antibiotics to market and fight this pressing menace to public well being. With out instant motion, we danger returning to a pre-antibiotic period the place widespread infections turn out to be lethal.”
On the finish of 2022, the U.S. Congress got here shut however did not go laws, called the Pasteur Act, which might have created incentives for drug corporations to develop new antimicrobials. The measure goals to create a assured marketplace for new antibiotics, which drug corporations say is required for them to spend money on analysis and improvement for brand new medicine. (As a result of new antibiotics have to be used sparingly, the market is taken into account too small for the hefty R&D price ticket concerned in growing new antimicrobials). The present state of political dysfunction means chances are high low that something will probably be enacted in Congress in 2023.
Well being journalists can make clear the necessity for coverage modifications by reporting on efforts at native hospitals, long-term care establishments and analysis establishments to watch and fight these microbes. One option to discover native tales is to have a look at the CDC investment map displaying which establishments are actively working with public well being officers on curbing antibiotic resistance.
One other story thought: lean into current pop culture interest in antimicrobial-resistant fungi linked to the streaming present “The Final of Us.” The HBO collection is predicated on a online game a few lethal fungus, referred to as cordyceps, that turns a lot of the earth’s people into zombies. Whereas fungi within the TV present solely infect bugs and are usually not a menace to people, there are 19 different resistant fungi which might be potential threats to people, in keeping with the WHO. A number of drug corporations are developing new medicine to combat them, however whether or not they are going to make it to the market with out monetary incentives is unclear. (See this Scientific American story on why the ‘Final of Us’ fungi isn’t one to fret about, however others are.)
For extra story concepts and sources, take a look at my AHCJ tip sheet for reporting on antibiotic resistance.